Emel Kılıçarslan

Emel Kılıçarslan

Auto-generated profile, based on publicly available information

Emel Kılıçarslan

Department of Pathology, Pamukkale University, 20160 Denizli, Türkiye

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2018 in Pathology International
Verified
Journal Article
Closed access
PDF file
SSSulen Sarioglu
Sulen Sarioglu
EKEmel Kilicarslan
Emel Kilicarslan
BABarbaros Aydin
Barbaros Aydin
MKMelih Arif Kozen
Melih Arif Kozen
FAFadime Akman
Fadime Akman
AIAhmet Omer Ikiz
Ahmet Omer Ikiz

1 March 2024 in Radiology
Verified
Journal Article
Closed access
FUFurkan Ufuk
Furkan Ufuk
EKEmel Kilicarslan
Emel Kilicarslan
FBFerda Bir
Ferda Bir
GAGoksel Altinisik
Goksel Altinisik
A 70-year-old woman with a 6-year history of asthma, a 12-year history of diabetes mellitus, and who did not smoke presented to the pulmonology clinic with dyspnea and cough. Chest CT performed 5 years earlier for similar symptoms revealed multiple pulmonary nodules. However, she was lost to follow-up before the work-up was concluded. Otherwise, her medical history was unremarkable. Family history included maternal endometrial cancer. Physical examination revealed partial oxygen saturation of 98%, respiratory rate of 18 breaths per minute, and heart rate of 77 beats per minute. Her breath sounds and other systemic findings were normal. Pulmonary function test results were as follows: forced expiratory volume in 1 second, 108% predicted (normal range, 80%-120%); total lung capacity, 72% predicted (normal range, 80%-120%); forced vital capacity, 101% predicted (normal range, 80%-120%); diffusing capacity for carbon monoxide, 69% predicted (normal range, 60%-120%); and forced midexpiratory flow, 85% predicted (normal range, 40%-160%). Complete blood count, erythrocyte sedimentation rate, C-reactive protein level, rheumatoid factor, and antinuclear antibody levels were within normal limits. The patient underwent volumetric thin-section CT of the chest using a multidetector CT scanner (Ingenuity Core 128; Philips Medical Systems) to evaluate lung nodules and pulmonary interstitium.

2 June 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
NYNilufer Yigit
Nilufer Yigit
EUErhan Uğurlu
Erhan Uğurlu
MSMeryem Sanlıalp
Meryem Sanlıalp
EKEmel Kılıçarslan
Emel Kılıçarslan
İAİlknur Hatice Akbudak
İlknur Hatice Akbudak
HŞHande Şenol
Hande Şenol
Background: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is the standard minimally invasive technique for mediastinal lymph node sampling; however, its diagnostic performance is limited in diseases requiring preserved tissue architecture, such as lymphoma and granulomatous disorders. EBUS-guided transbronchial mediastinal cryobiopsy (EBUS-TBMC) has emerged as a technique capable of obtaining larger, histologically intact samples. Evidence comparing these modalities in isolated mediastinal lymphadenopathy is limited. Methods: In this prospective, single-center, head-to-head cohort study, 89 consecutive patients with isolated mediastinal lymphadenopathy without parenchymal lung masses were enrolled. All patients underwent sequential EBUS-TBNA followed by EBUS-TBMC within the same session. The primary outcome was diagnostic yield; secondary outcomes included tissue adequacy and procedure-related complications. Results: EBUS-TBMC demonstrated a significantly higher diagnostic yield than EBUS-TBNA (83.1% vs. 28.0%, p < 0.001). TBMC established a diagnosis in 74/89 patients, whereas TBNA was diagnostic in 25/89. TBMC provided an additional diagnosis in 49 patients with non-diagnostic TBNA, while no case was diagnosed exclusively by TBNA. Superiority was consistent across malignant and benign conditions, particularly lymphoma and granulomatous diseases. Diagnostic yield was higher when ≥3 cryobiopsy samples were obtained (86.6% vs. 42.8%). Bleeding events were more frequent with TBMC but were mild-to-moderate, managed bronchoscopically, and no major complications or life-threatening events occurred. Conclusions: In isolated, mass-negative mediastinal lymphadenopathy, EBUS-TBMC provides a substantially higher diagnostic yield than TBNA. Early integration of TBMC may improve diagnostic efficiency and reduce the need for repeat or surgical procedures.

18 September 2025 in Journal of Chest Surgery
Verified
Journal Article
Open access
PDF file
AKArgün Kış
Argün Kış
EZEren Zenci
Eren Zenci
EKEmel Kılıçarslan
Emel Kılıçarslan
Argün Kış, M.D., Eren Zenci, M.D., Emel Kılıçarslan, M.D.. J Chest Surg -0001;0:. https://doi.org/10.5090/jcs.25.046

5 July 2025 in Journal of Molecular Histology
Verified
Journal Article
Closed access
PDF file
UÖUbeydullah Öztürk
Ubeydullah Öztürk
EKEmel Kılıçarslan
Emel Kılıçarslan
BTBurcu Yapar Taşköylü
Burcu Yapar Taşköylü
SÖSevin Başer Öncel
Sevin Başer Öncel
FBFerda Bir
Ferda Bir

1 November 2023 in Radiology
Verified
Journal Article
Closed access
FUFurkan Ufuk
Furkan Ufuk
EKEmel Kilicarslan
Emel Kilicarslan
FBFerda Bir
Ferda Bir
GAGoksel Altinisik
Goksel Altinisik
A 70-year-old woman with a 6-year history of asthma, a 12-year history of diabetes mellitus, and who did not smoke presented to the pulmonology clinic with dyspnea and cough. Chest CT performed 5 years earlier for similar symptoms revealed multiple pulmonary nodules (Fig 1). However, she was lost to follow-up before the work-up was concluded. Otherwise, her medical history was unremarkable. Family history included maternal endometrial cancer. Physical examination revealed partial oxygen saturation of 98%, respiratory rate of 18 breaths per minute, and heart rate of 77 beats per minute. Her breath sounds and other systemic findings were normal. Pulmonary function test results were as follows: forced expiratory volume in 1 second, 108% predicted (normal range, 80%-120%); total lung capacity, 72% predicted (normal range, 80%-120%); forced vital capacity, 101% predicted (normal range, 80%-120%); diffusing capacity for carbon monoxide, 69% predicted (normal range, 60%-120%); and forced midexpiratory flow, 85% predicted (normal range, 40%-160%). Complete blood count, erythrocyte sedimentation rate, C-reactive protein level, rheumatoid factor, and antinuclear antibody levels were within normal limits. The patient underwent volumetric high-resolution CT of the chest using a multidetector CT scanner (Ingenuity Core 128; Philips Medical Systems) to evaluate lung nodules and pulmonary interstitium (Fig 2).